HilleVax (NASDAQ:HLVX) Trading 6.2% Higher

HilleVax, Inc. (NASDAQ:HLVX – Get Rating)’s share price traded up 6.2% during trading on Friday . The stock traded as high as $16.62 and last traded at $16.62. 4 shares traded hands during mid-day trading, a decline of 100% from the average session volume of 38,379 shares. The stock had previously closed at $15.65.

HilleVax Stock Performance

The company has a quick ratio of 34.77, a current ratio of 34.77 and a debt-to-equity ratio of 0.02. The stock has a fifty day moving average price of $16.63 and a two-hundred day moving average price of $16.26.

HilleVax (NASDAQ:HLVX – Get Rating) last issued its quarterly earnings data on Thursday, November 10th. The company reported ($0.45) earnings per share for the quarter, beating the consensus estimate of ($0.88) by $0.43. Equities research analysts anticipate that HilleVax, Inc. will post -6.93 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Strs Ohio bought a new position in HilleVax in the 2nd quarter valued at $32,000. TD Asset Management Inc. bought a new stake in HilleVax in the second quarter worth about $203,000. Frazier Life Sciences Management L.P. purchased a new position in HilleVax in the second quarter valued at about $101,493,000. JPMorgan Chase & Co. bought a new position in shares of HilleVax during the 2nd quarter valued at approximately $76,000. Finally, Alps Advisors Inc. purchased a new stake in shares of HilleVax during the 2nd quarter worth approximately $217,000. 99.11% of the stock is currently owned by hedge funds and other institutional investors.

About HilleVax

(Get Rating)

HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus and related illness. The company was formerly known as MokshaCo, Inc and changed its name to HilleVax, Inc in February 2021.